In January, implementation management company Expo Technologies acquired SpectrAlliance, which provides PAT (the FDA’s Process and Analytical Technology initiative) focused software, including NovaPAC. Yokogawa Electric appointed Shuzo Kaihori, director and senior vice president of the Industrial Automation Business, representative director and president effective April 1. President Isao Uchida was named chairman. Under a partnership agreement, […]

Intelligent Bio-Systems exclusively licensed DNA sequencing technology from Columbia University. Beckman Coulter appointed James V. Mazzo, president and CEO of Advanced Medical Optics, to its board. Under a collaboration agreement, BG Medicine will integrate Applied Biosystems technology into its proteomic and metabolomic systems pharmacology workflows. Kyodo International will represent lab-on-a-chip company Micronit Microfluidics BV in […]

KBC Private Equity acquired a 75% stake in bioinformatics company Applied Maths NV in 2006. SAS and Ingenuity Systems integrated their respective JMP Genomics and Pathways Analysis solutions. Ingenuity Systems partnered with Compendia Bioscience, a provider of cancer profiling data and analysis tools, to integrate their respective Oncomine Professional and Pathways Analysis solutions. Thermo Fisher […]

Sequenom and QIAGEN GmbH entered into a strategic collaboration to jointly develop a preanalytical solution for small molecule (fetal) DNA enrichment for prenatal diagnostics. Sequenom will retain exclusive distribution rights to the technology for enriching short nucleic acids. In February, Sequenom named Steven Owings to the newly created position of vice president of Commercial Development, […]

According to David Bannon, COO and cofounder of Headwall Photonics, the headwall is usually the most difficult part of a mountain climb. It is from this willingness to take on difficult technological challenges, as well as the need for cooperation that climbing entails, that Headwall Photonics takes its name. The company’s prospects have been rising […]

Agilent’s ambitions continue to grow. After a successful 2006 (see IBO 1/15/07), which saw it enter the high-end mass spectrometry (MS) market, the company has set its sights on other market segments. In late March, Agilent announced the formation of a Materials Sciences Solutions Unit (MSSU) within its Life Science and Chemical Analysis (LSCA) business […]

Santa Clara, CA 4/6/07; La Jolla, CA 4/6/07—Agilent Technologies has signed a definitive agreement to purchase Stratagene for $10.94 per share of common stock, a 28% premium over Stratagene’s April 5 closing prices, or approximately $246.2 million in cash. Stratagene’s products include reagents and instruments for life science research and clinical diagnostics. “We see Stratagene’s […]

Dr. Karen A. Holbrook, president of Ohio State University, joined Techne’s board in February. In February, BD Biosciences and Roche announced a collaboration to jointly identify and develop intracellular phosphorylation site antibodies. The companies will develop and validate the antibodies using BD Phosflow technology, and Roche will receive pre-launch access to the antibodies and a […]